Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Samir Narayan

Showing results (1-10 of 36) with videos related to

Pageof 4
Sort By:
Current Opinion in Otolaryngology & Head and Neck Surgery|July 14, 2005
The use of intensity-modulated radiation therapy in the treatment of oropharyngeal carcinomaSamir Narayan
Nature Clinical Practice. Oncology|September 7, 2006
Multimodality therapy for Pancoast tumorSamir Narayan, Charles R Thomas
Seminars in Radiation Oncology|May 3, 2003
Chemotherapy for localized, high-risk prostate cancerSamir Narayan, David C Smith, Howard M Sandler
Seminars in Oncology|August 9, 2003
Combined modality treatment for prostate cancer: role of chemotherapyHoward M Sandler, Samir Narayan, David C Smith
Head & Neck|September 18, 2008
Palliative radiation therapy for head and neck cancer: toward an optimal fractionation schemeAllen M Chen, Andrew Vaughan, Samir Narayan, et al.
BMC Cancer|December 22, 2004
An electronic application for rapidly calculating Charlson comorbidity scoreWilliam H Hall, Ramanathan Ramachandran, Samir Narayan, et al.
International Journal of Radiation Oncology, Biology, Physics|May 10, 2003
Preliminary visual outcomes after three-dimensional conformal radiation therapy for optic nerve sheath meningiomaSamir Narayan, Wayne T Cornblath, Howard M Sandler, et al.
Frontiers of Radiation Therapy and Oncology|July 21, 2007
Introducing new technologies into the clinicSrinivasan Vijayakumar, Samir Narayan, Claus Chunli Yang, et al.
Nutrients|March 13, 2025
Nutritional Status of Children Under Five Years in the Slums of West Bengal, India: A Cross-Sectional Study on Prevalence, Characteristics, and DeterminantsAbdul Jaleel, Swapan Bikash Saha, N Arlappa, et al.
Lung Cancer (Amsterdam, Netherlands)|March 12, 2004
Results following treatment to doses of 92.4 or 102.9 Gy on a phase I dose escalation study for non-small cell lung cancerSamir Narayan, George T Henning, Randall K Ten Haken, et al.
Pageof 4

Showing results (1-10 of 36) with videos related to

Sort By:
Pageof 4
Current Opinion in Otolaryngology & Head and Neck Surgery|July 14, 2005
The use of intensity-modulated radiation therapy in the treatment of oropharyngeal carcinomaSamir Narayan
Nature Clinical Practice. Oncology|September 7, 2006
Multimodality therapy for Pancoast tumorSamir Narayan, Charles R Thomas
Seminars in Radiation Oncology|May 3, 2003
Chemotherapy for localized, high-risk prostate cancerSamir Narayan, David C Smith, Howard M Sandler
Seminars in Oncology|August 9, 2003
Combined modality treatment for prostate cancer: role of chemotherapyHoward M Sandler, Samir Narayan, David C Smith
Head & Neck|September 18, 2008
Palliative radiation therapy for head and neck cancer: toward an optimal fractionation schemeAllen M Chen, Andrew Vaughan, Samir Narayan, et al.
BMC Cancer|December 22, 2004
An electronic application for rapidly calculating Charlson comorbidity scoreWilliam H Hall, Ramanathan Ramachandran, Samir Narayan, et al.
International Journal of Radiation Oncology, Biology, Physics|May 10, 2003
Preliminary visual outcomes after three-dimensional conformal radiation therapy for optic nerve sheath meningiomaSamir Narayan, Wayne T Cornblath, Howard M Sandler, et al.
Frontiers of Radiation Therapy and Oncology|July 21, 2007
Introducing new technologies into the clinicSrinivasan Vijayakumar, Samir Narayan, Claus Chunli Yang, et al.
Nutrients|March 13, 2025
Nutritional Status of Children Under Five Years in the Slums of West Bengal, India: A Cross-Sectional Study on Prevalence, Characteristics, and DeterminantsAbdul Jaleel, Swapan Bikash Saha, N Arlappa, et al.
Lung Cancer (Amsterdam, Netherlands)|March 12, 2004
Results following treatment to doses of 92.4 or 102.9 Gy on a phase I dose escalation study for non-small cell lung cancerSamir Narayan, George T Henning, Randall K Ten Haken, et al.
Pageof 4